FDA grants emergency use authorization for Simparica TRIO to treat New World screwworm in dogs and puppies
The U.S. Food and Drug Administration issued an Emergency Use Authorization for Simparica TRIO, a chewable tablet containing sarolaner, moxidectin and pyrantel, to treat New World screwworm infestations in dogs and puppies.
Most U.S. dogs are at low risk, but those living in, traveling to, or returning from areas where the parasite has been identified-particularly parts of Texas, New Mexico, and some countries south of the border-should be closely watched for signs such as visible maggots or foul odors.
Veterinarians are urged to provide immediate care for any suspected cases, and the USDA maintains an online dashboard of confirmed detections. The FDA’s action adds another treatment option to help contain any potential spread.
This writeup was produced by pharmadog from original reporting by fda press.
Original headline: “FDA Issues Emergency Use Authorization for Drug to Treat New World Screwworm in Dogs and Puppies”
read at fda press ↗
comments(0)
5-min edit window · permanent after that